Ignite Creation Date:
2024-05-06 @ 8:08 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06263530
Status:
RECRUITING
Last Update Posted:
2024-02-16
First Post:
2023-11-14
Brief Title:
Prognostic Significance of ctDNA in HL
Sponsor:
Organization:
Interni hematologicka klinika FNKV
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
Identification of tumor specific mutation profiles at diagnosis of classical Hodgkin lymphoma Quantitative analysis of ctDNA level during the first-line chemotherapy Identification of tumor specific mutation profiles at relapse of classical Hodgkin lymphoma In vitro functional characterization of identified DNA variants andor mutations
Enrollment Count:
500
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Case-Control |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 103831 |
Who Masked List: